Steve Lenier

Steve Lenier

Contributing Writer

Steve Lenier began a career in medical literature over 30 years ago. He has worked on a variety of publications and projects, and across a number of specialties. Since 2005 most of his time has been spent covering ophthalmology, both print and online.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
Adverum, Gene Therapy, and AMD

March 25 2020

Adverum, Gene Therapy, and AMD

Adverum, a company pioneering novel gene therapies for ocular diseases, believes a gene therapy treatment for wet age-related macular degeneration (AMD) can reduce treatment burden ...
Read More
Innovations a Highlight at Dry Eye Breakout Session

January 8 2020

Innovations a Highlight at Dry Eye Breakout Session

The dry eye disease (DED) market is expected to have an annual compound growth rate of 4.5% between 2017 and 2025, which should help it ...
Read More
BioGenware’s Speculet Seeks to Improve the Patient Experience

December 18 2019

BioGenware’s Speculet Seeks to Improve the Patient Experience

For those undergoing intravitreal injections (and there are about 22 million of these performed yearly worldwide), a common complaint is that the speculum is uncomfortable, ...
Read More
Bausch, Clearside See Gains Post-Deal

November 20 2019

Bausch, Clearside See Gains Post-Deal

When it comes to the stock market, Bausch Health’s has been rising steadily, up 4.1% in the past month, and on November 13 hit a ...
Read More
Private Financing Trends: Ophthalmology Ranks Tenth

November 7 2019

Private Financing Trends: Ophthalmology Ranks Tenth

SAN FRANCISCO, Calif. — Almost $25 billion in venture funds have been raised in just the United States alone over the past 2.5 years to ...
Read More
Ain’t Misbehaving

October 23 2019

Ain’t Misbehaving

What a difference a day (or so) makes. On Oct. 10, the day of the Ophthalmic Innovation Summit, Aerie Pharmaceuticals' stock closed at $17.72. The ...
Read More
What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

September 25 2019

What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

SAN FRANCISCO — Winners of a “Shark Tank” style challenge in cataract/refractive and retina and specialty showcase sessions targeting four themes, including gene and cell ...
Read More
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

September 18 2019

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

LensGen CEO Ramgopal Rao says the company has been built around a laser focus on customers’ needs and wants. That led LensGen to identify a ...
Read More
5 Factors for Evaluating Investments in the Retina Space

September 11 2019

5 Factors for Evaluating Investments in the Retina Space

As noted in a previous installment, innovators in the retina space sometimes utilize ex-US partnerships for financing the expensive process of taking drugs and devices ...
Read More
As Retina Innovators Look Outside US for Funding, Here’s What to Watch Out For

September 4 2019

As Retina Innovators Look Outside US for Funding, Here’s What to Watch Out For

CHICAGO – As innovation in the retina space has grown over the past quarter century, so has the need for capital to finance those activities. ...
Read More
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20 2019

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

In traditional cataract surgery, the surgeon removes the clouded natural lens and replaces it with a synthetic intraocular lens (IOL), placing it into the capsular ...
Read More
Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

August 1 2019

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

Carl Zeiss Meditec has made a series of strategic moves in recent weeks in glaucoma, retina, cataract, and refractive, along with reaching a milestone on ...
Read More